GB1422974A - Drying process - Google Patents

Drying process

Info

Publication number
GB1422974A
GB1422974A GB1689073A GB1689073A GB1422974A GB 1422974 A GB1422974 A GB 1422974A GB 1689073 A GB1689073 A GB 1689073A GB 1689073 A GB1689073 A GB 1689073A GB 1422974 A GB1422974 A GB 1422974A
Authority
GB
United Kingdom
Prior art keywords
spray
bloom
hydrolyzed gelatin
silicic acid
sodium benzoate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1689073A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB1422974A publication Critical patent/GB1422974A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/148Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with compounds of unknown constitution, e.g. material from plants or animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5052Proteins, e.g. albumin
    • A61K9/5057Gelatin
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D1/00Evaporating
    • B01D1/16Evaporating by spraying
    • B01D1/18Evaporating by spraying to obtain dry solids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
GB1689073A 1972-04-10 1973-04-09 Drying process Expired GB1422974A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24278972A 1972-04-10 1972-04-10

Publications (1)

Publication Number Publication Date
GB1422974A true GB1422974A (en) 1976-01-28

Family

ID=22916188

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1689073A Expired GB1422974A (en) 1972-04-10 1973-04-09 Drying process

Country Status (8)

Country Link
JP (1) JPS5418331B2 (US06653308-20031125-C00199.png)
AT (1) AT353232B (US06653308-20031125-C00199.png)
BE (1) BE797921A (US06653308-20031125-C00199.png)
CH (1) CH586568A5 (US06653308-20031125-C00199.png)
DE (1) DE2317434A1 (US06653308-20031125-C00199.png)
FR (1) FR2179899B1 (US06653308-20031125-C00199.png)
GB (1) GB1422974A (US06653308-20031125-C00199.png)
NL (1) NL7304921A (US06653308-20031125-C00199.png)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0088382A1 (en) * 1982-03-09 1983-09-14 Nippon Shinyaku Company, Limited Stabilization of azulene derivatives
WO2008130883A1 (en) * 2007-04-16 2008-10-30 Wyeth Embedded liquid lubricants for tableting
EP1811008A3 (en) * 2006-01-18 2009-12-16 Joseph Iannicelli Method and composition for controlled heat release and disposable chemical heater utilizing same
US9891239B2 (en) 2007-02-23 2018-02-13 Gilead Sciences, Inc. Modulators of pharmacokinetic properties of therapeutics
US10039718B2 (en) 2008-05-02 2018-08-07 Gilead Sciences, Inc. Use of solid carrier particles to improve the processability of a pharmaceutical agent

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2546838B2 (ja) * 1986-03-24 1996-10-23 エフ・ホフマン―ラ ロシユ アーゲー ビタミン製剤の製造方法
JP3555640B2 (ja) * 1996-05-10 2004-08-18 ライオン株式会社 天然カロチノイドを包含した多芯型構造のマイクロカプセル並びに錠剤、食品用及び医薬品用配合剤
EP2127642A3 (en) * 1998-08-13 2010-02-24 Cima Labs, Inc. Microemulsions as solid dosage forms for oral administration
JP2000086537A (ja) * 1998-09-11 2000-03-28 Fuji Chem Ind Co Ltd 無機化合物糖類組成物、賦形剤、速崩壊性圧縮成型物及びその製造方法
AU2001241730B2 (en) * 2001-02-23 2007-03-15 Cima Labs Inc. Emulsions as solid dosage forms for oral administration
JP5900983B2 (ja) * 2010-12-27 2016-04-06 ディーエスエム アイピー アセッツ ビー.ブイ. 改良粉末ビタミンe製剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1266902A (fr) * 1960-09-06 1961-07-17 Procédé de production de préparations stables de vitamines
FR1546920A (fr) * 1966-12-02 1968-11-22 Niro Atomizer As Roue d'atomisation simultanée de deux composants
US3608083A (en) * 1968-06-05 1971-09-21 Hoffmann La Roche Vitamin e powder

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0088382A1 (en) * 1982-03-09 1983-09-14 Nippon Shinyaku Company, Limited Stabilization of azulene derivatives
EP1811008A3 (en) * 2006-01-18 2009-12-16 Joseph Iannicelli Method and composition for controlled heat release and disposable chemical heater utilizing same
US8080172B2 (en) 2006-01-18 2011-12-20 J.I. Enterprises, Inc. Method and composition for controlled heat release and disposable chemical heater utilizing same
US9891239B2 (en) 2007-02-23 2018-02-13 Gilead Sciences, Inc. Modulators of pharmacokinetic properties of therapeutics
WO2008130883A1 (en) * 2007-04-16 2008-10-30 Wyeth Embedded liquid lubricants for tableting
AU2008242256B2 (en) * 2007-04-16 2011-11-03 Pf Consumer Healthcare 1 Llc Embedded liquid lubricants for tableting
EP2599394A1 (en) * 2007-04-16 2013-06-05 Wyeth LLC Embedded liquid lubricants for tableting
US11013251B2 (en) 2007-04-16 2021-05-25 PF Consumer Healthcare 1, LLC Embedded liquid lubricants for tableting
US10039718B2 (en) 2008-05-02 2018-08-07 Gilead Sciences, Inc. Use of solid carrier particles to improve the processability of a pharmaceutical agent

Also Published As

Publication number Publication date
JPS497415A (US06653308-20031125-C00199.png) 1974-01-23
AT353232B (de) 1979-11-12
CH586568A5 (US06653308-20031125-C00199.png) 1977-04-15
JPS5418331B2 (US06653308-20031125-C00199.png) 1979-07-06
FR2179899B1 (US06653308-20031125-C00199.png) 1976-09-10
FR2179899A1 (US06653308-20031125-C00199.png) 1973-11-23
NL7304921A (US06653308-20031125-C00199.png) 1973-10-12
BE797921A (fr) 1973-10-09
DE2317434A1 (de) 1973-12-06
ATA310873A (de) 1979-04-15

Similar Documents

Publication Publication Date Title
GB1422974A (en) Drying process
CA2176841A1 (en) Feed additive
CA2260637A1 (en) Free-flowable, directly compressible starch as binder, distinegrant and filler for compression tablets and hard gelatine capsules
IE791669L (en) Preparation of gels
GB1310925A (en) Methods of forming direct compression vehicles and tablets
US3875282A (en) Production of high bulk density spray dried hydrous sodium silicate
JPS5753403A (en) Composition containing spray dry particle of n-acetyl-p-aminophenol and manufacture
ES471589A1 (es) Procedimiento para la estabilizacion de percarbonato de so- dio
GB1346152A (en) Powder compositions
ES393211A1 (es) Un procedimiento para la fabricacion de derivados de almi- don hidrofobos redispersables.
US2631977A (en) Free flowing fire extinguishing compositions
JPH0566928B2 (US06653308-20031125-C00199.png)
CA1199871A (en) Drug preparations for glycoside hydrolase inhibitors
IE801402L (en) Gastric acid neutralizing agents
ES8101516A1 (es) Procedimiento de preparacion en forma semi-continua de zeo- lita a.
GB1401295A (en) Process for the production of hydrated mixed metal silicates
JPS557018A (en) Melt coating preparation comprising sorbic acid
CA2130480A1 (en) Agglomeration of alumina material
GB1340404A (en) Sodium tripolyphosphate
ES8100343A1 (es) Un procedimiento para obtener un producto de tripolifosfato sodico granular
GB1476682A (en) Bleaching formulation
IE42783L (en) Aluminium polyhydroxysulphate
ES483956A1 (es) Un procedimiento para la preparacion de un producto comes- tible deshidratado.
ES380779A1 (es) Procedimiento para la preparacion de composiciones antiaci-das.
US5108726A (en) Compacts of spray dried water soluble compounds

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee